Improving HIV care engagement for Latinos
ADELANTE: A Randomized Controlled Trial of an Intervention to Improve Engagement in Care for Latinos With HIV
NA · Massachusetts General Hospital · NCT06274632
This study is testing a new program called ADELANTE to see if it helps Latinos with HIV better manage their health and achieve lower viral levels compared to just getting reminder phone calls.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Massachusetts General Hospital (other) |
| Locations | 2 sites (Miami, Florida and 1 other locations) |
| Trial ID | NCT06274632 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of the ADELANTE intervention, a community health worker-delivered program, in improving viral suppression among Latinos with HIV. Participants will be randomly assigned to receive either ADELANTE, which includes five sessions focused on problem-solving and self-management skills, or an enhanced care condition that consists of reminder phone calls. The study will measure outcomes such as rates of viral suppression and emergency room visits over a 12-month period. Participants will be recruited from clinics in areas with high HIV incidence and will be compensated for their involvement.
Who should consider this trial
Good fit: Ideal candidates are Latino adults aged 18 and older who have been on HIV treatment for at least six months and show evidence of viral non-suppression.
Not a fit: Patients who lack the capacity to consent or are currently participating in another HIV intervention study may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could lead to improved health outcomes and better management of HIV for Latino patients.
How similar studies have performed: Other studies have shown promise in using community health workers to improve health outcomes in similar populations, indicating a potential for success with this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identify as Latino/Latina/Latinx/Hispanic; adults 18 years and over; with HIV infection confirmed by standard laboratory results available in the medical record; 3 or more months from initial entry into care with a medical provider who can prescribe HIV antiretroviral treatment; receiving HIV primary care at Jackson Memorial Hospital or Thomas Street at Quentin Mease Health Center/Harris Health System; and medical record evidence with last viral load (VL) indicating viral non-suppression (HIV RNA ≥200 cpm) within 12 months prior to assessment of eligibility, as it is typical for providers to obtain laboratories prior to a clinic visit in preparation for counseling. Exclusion Criteria: * Lacks capacity to consent (measured by a validated screener), plans to move out of the county in the next 6 months, or currently participating in an HIV intervention study with ongoing follow-up.
Where this trial is running
Miami, Florida and 1 other locations
- University of Miami — Miami, Florida, United States (RECRUITING)
- Baylor College of Medicine — Houston, Texas, United States (RECRUITING)
Study contacts
- Study coordinator: Julie H Levison, MD
- Email: jlevison@mgb.org
- Phone: 617-724-4698
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: HIV/AIDS, Latino, Hispanic, health outcomes, community health worker